| Literature DB >> 27702851 |
Sven Reek1,2, Haran Burri3, Paul R Roberts4, Christian Perings5, Andrew E Epstein6, Helmut U Klein7, Gregory Lip, Bulent Gorenek, Christian Sticherling, Laurent Fauchier, Andreas Goette, Werner Jung, Marc A Vos, Michele Brignole, Christian Elsner, Gheorghe-Andrei Dan, Francisco Marin, Giuseppe Boriani, Deirdre Lane, Carina Blomström-Lundqvist, Irina Savelieva.
Abstract
The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable cardioverter-defibrillator. The use of the wearable cardioverter-defibrillator is included in the new 2015 ESC guidelines for the management of ventricular arrhythmias and prevention of sudden cardiac death. The present review provides insight into the current technology and an overview of this approach. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: External defibrillation; Life vest; Sudden cardiac death; Ventricular arrhythmias; Wearable cardioverter-defibrillator
Mesh：
Year: 2017 PMID： 27702851 DOI： 10.1093/europace/euw180
Source DB: PubMed Journal: Europace ISSN： 1099-5129 Impact factor: 5.214